Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gerostate Alpha
AddedFeb 18, 2024
UpdatedJul 3, 2026
Gerostate Alpha

Gerostate Alpha

Closed

Gerostate Alpha: A pharmaceutical company innovating in aging and age-related disease treatment.

HQ
Novato, CA, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorS18
Overview
Compare
Fundraising
Employees

Gerostate Alpha, founded with the mission to treat aging and age-related diseases, is a pioneering pharmaceutical company incubated at the Buck Institute for Research on Aging. The company's vision is to develop breakthrough pharmaceuticals that mitigate and reduce the effects of aging through proprietary innovations. Gerostate Alpha focuses on leveraging over thirty years of research in the biology of aging to create effective treatments that challenge the inevitability of aging.

Notable affiliated individuals include researchers and scientists from the Buck Institute for Research on Aging, a leading institution in the field. Gerostate Alpha has achieved significant milestones in developing its pharmaceutical pipeline, contributing to the growing body of knowledge on aging and age-related diseases. The company's impact lies in its potential to revolutionize how society approaches aging, offering hope for extended healthspan and improved quality of life for the aging population.

Gerostate Alpha - Similar Companies

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Retro Biosciences logo

Retro Biosciences

retro.bio

AgeX Therapeutics logo

AgeX Therapeutics

BioAge Labs logo

BioAge Labs

bioagelabs.com

Generation Lab logo

Generation Lab

generationlab.co

Juvenescence logo

Juvenescence

juvlabs.com

Rejuvenation Technologies Inc. logo

Rejuvenation Technologies Inc.

Longeveron logo

Longeveron

longeveron.com

Altos Labs logo

Altos Labs

altoslabs.com

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

Forever Labs logo

Forever Labs

foreverlabs.com

Rubedo Life Sciences logo

Rubedo Life Sciences

rubedolife.com

Lifespan Vision Ventures logo

Lifespan Vision Ventures

Oisin Biotechnologies logo

Oisin Biotechnologies

oisinbio.com

Gerostate Alpha - Quick Facts

Who are Gerostate Alpha's competitors?

Companies similar to Gerostate Alpha include Rejuveron Life Sciences, Regenerative Bio, Retro Biosciences and AgeX Therapeutics.

When was Gerostate Alpha founded?

Gerostate Alpha was founded in 2018.

Where is Gerostate Alpha's headquarters located?

Gerostate Alpha's headquarters is located in Novato, CA, US.

How much has Gerostate Alpha raised to-date?

As of Apr 15, 2019, Gerostate Alpha has raised a total of $150k (USD).

Gerostate Alpha - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified